| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.39M | $441.12M | - | |
| CEO | 890.4K | $53.16M | - | |
| CEO | 875.0K | $52.24M | - | |
| Other | 740.2K | $44.19M | - | |
| COO | 215.3K | $12.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 | Kintz Samuel50 | President And CEO | Sell | 10,983 | $20.02 | $219,906.31 | -0.6% | +10.1% | - | |
| Aug 7, 2025 | Patel Anish53 | Chief Operating Officer | Sell | 6,667 | $18.24 | $121,615.52 | -1.1% | +3.4% | - | |
| Jul 28, 2025 | Hohl Benjamin59 | Chief Financial Officer | Sale+OE | 3,250 | $20.46 | $66,503.76 | -6.6% | +3.5% | +160.1% | |
| Jul 21, 2025 | Lyssikatos Joseph P49 | Chief Scientific Officer | Sell | 12,500 | $22.29 | $278,645.80 | -0.7% | +1.1% | +148.4% | |
| Jul 17, 2025 | Kintz Samuel50 | President And CEO | Sell | 12,500 | $22.52 | $281,517.86 | -0.4% | -6.9% | +127.9% | |
| Jul 10, 2025 | Hohl Benjamin59 | Chief Financial Officer | Sale+OE | 1,000 | $22.66 | $22,655.00 | -4.2% | -10.8% | +124.3% | |
| Jul 7, 2025 | Patel Anish53 | Chief Operating Officer | Sell | 6,667 | $19.79 | $131,950.60 | -1.1% | +3.6% | +159.9% | |
| Jun 27, 2025 | Hohl Benjamin59 | Chief Financial Officer | Sale+OE | 3,250 | $20.91 | $67,955.81 | -6.6% | -10.2% | +142.2% | |
| Jun 20, 2025 | Lyssikatos Joseph P49 | Chief Scientific Officer | Sell | 12,500 | $21.40 | $267,457.50 | -1.3% | -6.5% | +115.8% | |
| Jun 17, 2025 | Kintz Samuel50 | President And CEO | Sell | 12,500 | $22.18 | $277,292.30 | -0.7% | -15.1% | +105.8% |